Metabolism resistant isothiazolone inhibitors of cartilage breakdown.
A series of 2-(arylmethyl)pyridoisothiazolones is reported that inhibit the IL-1 beta induced breakdown of bovine nasal septum cartilage in an organ culture assay. The synthesis and preliminary SAR of these compounds are described. These compounds represent a novel, non-peptide lead series approach to the mediation of the chronic cartilage breakdown associated with arthritic disease. These compounds are relatively resistant to reductive metabolism by liver microsomal preparations and appear to inhibit cartilage breakdown by interfering with the proteolytic activation of matrix metalloproteinases.
Wright
S W
SW
Du Pont Merck Pharmaceutical Company, Wilmington, DE 19880, USA.
Petraitis
J J
JJ
Batt
D G
DG
Corbett
R L
RL
Di Meo
S V
SV
Freimark
B
B
Giannaras
J V
JV
Orwat
M J
MJ
Pinto
D J
DJ
Pratta
M A
MA
D000818:Animals; D002356:Cartilage / Q000378:metabolism*; D002417:Cattle; D007213:Indomethacin / Q000494:pharmacology; D007375:Interleukin-1 / Q000037:antagonists & inhibitors / Q000378:metabolism; D019278:Matrix Metalloproteinase 3; D008666:Metalloendopeptidases / Q000037:antagonists & inhibitors / Q000378:metabolism; D008861:Microsomes / Q000378:metabolism; D009288:Naproxen / Q000494:pharmacology; D009300:Nasal Septum; D009924:Organ Culture Techniques; D010084:Oxidation-Reduction / Q000187:drug effects; D011509:Proteoglycans / Q000378:metabolism; D011720:Pyrazoles / Q000494:pharmacology; D011725:Pyridines / Q000138:chemical synthesis / Q000737:chemistry / Q000494:pharmacology*; D013329:Structure-Activity Relationship; D013844:Thiazoles / Q000138:chemical synthesis / Q000737:chemistry / Q000494:pharmacology*
D007375:Interleukin-1; D011509:Proteoglycans; D011720:Pyrazoles; D011725:Pyridines; D013844:Thiazoles; D009288:Naproxen; D008666:Metalloendopeptidases; D019278:Matrix Metalloproteinase 3; C015429:phenidone; D007213:Indomethacin